Literature DB >> 36116722

Billiary casts in post-COVID-19 cholangiopathy.

Jonathan Soldera1, Raul Angelo Balbinot2, Silvana Sartori Balbinot2.   

Abstract

Entities:  

Year:  2022        PMID： 36116722      PMCID： PMC9476357          DOI： 10.1016/j.gastrohep.2022.08.008

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN： 0210-5705            Impact factor:   5.867


× No keyword cloud information.
  5 in total

1.  Post-COVID-19 Cholangiopathy: A Novel Entity.

Authors:  Nitzan C Roth; Angela Kim; Taisia Vitkovski; Jianxiang Xia; Guillermo Ramirez; David Bernstein; James M Crawford
Journal:  Am J Gastroenterol       Date:  2021-05-01       Impact factor: 10.864

2.  Secondary sclerosing cholangitis: A complication after severe COVID-19 infection.

Authors:  Nazaret María Pizarro Vega; Paz Valer Lopez-Fando; Gema de la Poza Gómez; Belén Piqueras Alcol; Marina Gil Santana; Paloma Ruiz Fuentes; Marcos Alfredo Rodríguez Amado; Fernando Bermejo San José
Journal:  Gastroenterol Hepatol       Date:  2022-05-13       Impact factor: 5.867

3.  Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.

Authors:  Saamia Faruqui; Fidelis C Okoli; Sonja K Olsen; David M Feldman; Harmit S Kalia; James S Park; Carmen M Stanca; Viviana Figueroa Diaz; Sarah Yuan; Nabil N Dagher; Suparna A Sarkar; Neil D Theise; Sooah Kim; Krishna Shanbhogue; Ira M Jacobson
Journal:  Am J Gastroenterol       Date:  2021-07-01       Impact factor: 10.864

4.  Predominance of SARS-CoV-2 P.1 (Gamma) lineage inducing the recent COVID-19 wave in southern Brazil and the finding of an additional S: D614A mutation.

Authors:  Meriane Demoliner; Mariana Soares da Silva; Juliana Schons Gularte; Alana Witt Hansen; Paula Rodrigues de Almeida; Matheus Nunes Weber; Fágner Henrique Heldt; Flávio Silveira; Micheli Filippi; Vyctoria Malayhka de Abreu Góes Pereira; Francini Pereira da Silva; Larissa Mallmann; Pietra Fink; Andréia Rosane de Moura Valim; Lia Gonçalves Possuelo; Juliane Deise Fleck; Fernando Rosado Spilki
Journal:  Infect Genet Evol       Date:  2021-11-09       Impact factor: 3.342
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.